Influence of the dietary history in the PREVENTion of Coeliac Disease: possibilities of induction of tolerance for gluten in genetic predisposed children

ISRCTN ISRCTN74582487
DOI https://doi.org/10.1186/ISRCTN74582487
Secondary identifying numbers NTR890
Submission date
26/02/2007
Registration date
26/02/2007
Last edited
27/05/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr M L Mearin
Scientific

Leiden University Medical Centre
Department Of Pediatrics
P.O. Box 9600
Leiden
2300 RC
Netherlands

Email M.L.Mearin_Manrique@lumc.nl

Study information

Study designRandomised placebo-controlled parallel-group double-blinded multicentre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Scientific titleRandomized Feeding Intervention in Infants at High Risk for Celiac Disease
Study acronymPREVENTCD
Study objectivesTo induce tolerance for gluten in genetically predisposed children for coeliac disease through the introduction of small quantities of gluten during the period of breast-feeding.
Ethics approval(s)Approval received from the Leiden University Medical Centre (LUMC), Commissie Medische Ethiek on the 1st December 2006 (ref: P06.177). Also the ethical review of the project received a positive opinion from the European Commission; the Commission of the European Communities - Research Directorate - General (Directorate E- Biotechnology, Agriculture and Food research) on the 11th September 2006 (ref: FOOD-CT-2006-36383).

Each partner in the PREVENTCD project has the approval of their local medical ethics board.
Health condition(s) or problem(s) studiedCoeliac disease
InterventionIn the family study:
1. The intervention group will get a small amount of gluten (1 gram of wheat flour = 100 mg gliadin) during the period of breastfeeding from the age of four months for eight weeks
2. The control group (placebo) will get milk sugar powder (1 g of lactose) during the period of breast feeding from the age of four months for eight weeks
Intervention typeOther
Primary outcome measureA reduction of 50% of CD among the intervention group at the age of three years will be considered as an effective prevention.
Secondary outcome measuresIf the proposed early dietary intervention results in effective prevention of CD:
1. Development of new European guidelines for early nutrition in order to prevent the disease
2. Identification of the influence of early feeding on the development of coeliac disease in relation with immunological and genetical factors
Overall study start date01/01/2007
Completion date31/12/2011

Eligibility

Participant type(s)Patient
Age groupChild
SexBoth
Target number of participants1000 (including participants from all centres)
Total final enrolment944
Key inclusion criteria1. Infant born during the study with a first degree relative (parent or sibling) with coeliac disease (CD)
2. Informed consent for the study
Key exclusion criteria1. No informed consent
2. Parents-guardians unable to understand the information necessary to give informed consent
Date of first enrolment26/05/2007
Date of final enrolment10/09/2013

Locations

Countries of recruitment

  • Croatia
  • Hungary
  • Israel
  • Italy
  • Netherlands
  • Poland
  • Spain

Study participating centre

Leiden University Medical Centre
Leiden
2300 RC
Netherlands

Sponsor information

Leiden University Medical Centre (LUMC) (The Netherlands)
Hospital/treatment centre

Department of Pediatrics
P.O. Box 9600
Leiden
2300 RC
Netherlands

Website http://www.lumc.nl/english/start_english.html#http://www.lumc.nl/english/start_english.html
ROR logo "ROR" https://ror.org/027bh9e22

Funders

Funder type

Government

European Commission (Belgium)
Government organisation / National government
Alternative name(s)
European Union, Comisión Europea, Europäische Kommission, EU-Kommissionen, Euroopa Komisjoni, Ευρωπαϊκής Επιτροπής, Европейската комисия, Evropské komise, Commission européenne, Choimisiúin Eorpaigh, Europskoj komisiji, Commissione europea, La Commissione europea, Eiropas Komisiju, Europos Komisijos, Európai Bizottságról, Europese Commissie, Komisja Europejska, Comissão Europeia, Comisia Europeană, Európskej komisii, Evropski komisiji, Euroopan komission, Europeiska kommissionen, EC, EU

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 02/10/2014 Yes No

Editorial Notes

27/05/2021: The following changes were made to the trial record:
1. The scientific title was added.
2. The total final enrolment was added.
3. The recruitment start date was changed from 01/01/2007 to 26/05/2007.
4. The recruitment end date was changed from 31/12/2011 to 10/09/2013.